Skip to main content
. 2023 Aug 1;10:1190885. doi: 10.3389/fmed.2023.1190885

Table 2.

Impact of smoking status on COPD development.

Sex Smoking status N Event Duration IR, per 1,000 PY HR (95% CI)
Model 1 Model 2 Model 3
Total Non 3,485,089 6,627 28963394.53 0.2288 1 (Ref.) 1 (Ref.) 1 (Ref.) Former 633,122 1,536 5367167.29 0.2862 1.247 (1.180–1.318) 1.208 (1.135–1.285) 1.206 (1.134–1.283) Current 2,189,365 5,626 18369092.08 0.3063 1.336 (1.290–1.385) 1.460 (1.394–1.529) 1.455 (1.389–1.524)
Male* Non 1,148,534 2,192 9605130.78 0.2282 1 (Ref.) 1 (Ref.) 1 (Ref.) Former 547,055 1,320 4670421.89 0.2826 1.235 (1.153–1.322) 1.116 (1.041–1.197) 1.115 (1.040–1.195) Current 2,039,294 5,193 17160746.25 0.3026 1.324 (1.260–1.392) 1.395 (1.324–1.469) 1.390 (1.320–1.464)
Female* Non 2,336,555 4,435 19358263.75 0.2291 1 (Ref.) 1 (Ref.) 1 (Ref.) Former 86,067 216 696745.4 0.3100 1.358 (1.185–1.557) 1.389 (1.210–1.595) 1.388 (1.210–1.594) Current 150,071 433 1208345.83 0.3583 1.573 (1.425–1.736) 1.658 (1.497–1.837) 1.654 (1.493–1.833)

Model 1, non-adjusted; Model 2, adjusted for age, sex, BMI, alcohol consumption, regular exercise, income, pneumonia, asthma; Model 3, adjusted for age, sex, BMI, alcohol consumption, regular exercise, income, pneumonia, asthma, diabetes mellitus, hypertension, dyslipidemia. *Sex was excluded from multivariate models. COPD, chronic obstructive pulmonary disease; IR, incidence rate; PY, person-year; HR, hazard ratio; CI, confidence interval; Ref., reference.